In Vitro activity of fosfomycin against a collection of clinical Pseudomonas aeruginosa isolates from 16 spanish hospitals: Establishing the validity of standard broth microdilution as susceptibility testing method

Antimicrobial Agents and Chemotherapy

Volumn 57, Issue 11, 2013, Pages 5701-5703

  Díez Aguilar, María ^a   Morosini, María Isabel ^a,b   Del Campo, Rosa ^a,b   García Castillo, María ^a,b   Zamora, Javier ^b,c   Cantóna, Rafael ^b  

^a HOSPITAL RAMÓN Y CAJAL   (Spain)

^b CIBER EPIDEMIOLOGÍA Y SALUD PÚBLICA CIBERESP   (Spain)

^c INSTITUTO RAMÓN Y CAJAL DE INVESTIGACIÓN SANITARIA IRYCIS   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

FOSFOMYCIN;

AGAR DILUTION; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIUM ISOLATE; BROTH DILUTION; CONTROLLED STUDY; DISK DIFFUSION; EPSILOMETER TEST; IN VITRO STUDY; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA;

AGAR; ANTI-BACTERIAL AGENTS; CULTURE MEDIA; FOSFOMYCIN; HUMANS; LINEAR MODELS; MICROBIAL SENSITIVITY TESTS; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS;

EID: 84885913086     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.00589-13     Document Type: Article

References (15)

1. Strateva T, Yordanov D. 2009. Pseudomonas aeruginosa-phenomenon of bacterial resistance. J. Med. Microbiol. 58:1133-1148.
2. Michalopoulos AS, Livaditis IG, Gougoutas V. 2011. The revival of fosfomycin. Int. J. Infect. Dis. 15:e732-3739. doi:10.1016/j.ijid.2011.07.007.
3. Dinh A, Salomon J, Bru JP, Bernard L. 2012. Fosfomycin: Efficacy against infections caused by multidrug-resistant bacteria. Scand. J. Infect. Dis. 44:182-189.
4. Falagas ME, Kastoris AC, Karageorgopoulos DE, Rafailidis PI. 2009. Fosfomycin for the treatment of infections caused by multidrug-resistant non-fermenting Gram-negative bacilli: A systematic review of microbiological, animal and clinical studies. Int. J. Antimicrob. Agents 34:111-120.
5. Clinical and Laboratory Standards Institute. 2012. Performance standards for antimicrobial susceptibility testing: 22nd informational supplement. M100-S22. CLSI, Wayne, PA.
6. European Committee on Antimicrobial Susceptibility Testing. 2012. Breakpoint tables for interpretation of MICs and zone diameter, version 2.0. http://www.eucast.org/.
7. García-Castillo M, del Campo R, Morosini MI, Riera E, Cabot G, Willems R, van Mansfeld R, Oliver A, Cantón R. 2011. Wide dispersion of ST175 clone despite high genetic diversity of carbapenemnonsusceptible Pseudomonas aeruginosa clinical strains in 16 Spanish hospitals. J. Clin. Microbiol. 49:2905-2910.
8. Lu CL, Liu CY, Huang YT, Teng LJ, Turnidge JD, Hsueh PR. 2011. Antimicrobial susceptibilities of commonly encountered bacterial isolates to fosfomycin determined by agar dilution and disk diffusion methods. Antimicrob. Agents Chemother. 55:4295-4301.
9. Clark RB, Lewinski MA, Loeffelholz MJ, Tibetts RJ. 2009. Cumitech 31A, Verification and validation of procedures in the clinical microbiology laboratory. Coordinating ed, Sharp SE. ASM Press, Washington, DC.
10. Leemis LM, Trivedi KS. 1996. A comparison of approximate interval estimators for the Bernoulli parameter. Am. Stat. 50:63-68.
11. Bland JM, Altman DG. 1986. Statistical methods for assessing agreement between two methods of clinical measurement. Lancet 327:307-310.
12. Landis JR, Koch GG. 1977. The measurement of observer agreement for categorical data. Biometrics 33:159-174.
13. Castañeda-García A, Rodríguez-Rojas A, Guelfo JR, Blázquez J. 2009. The glycerol-3-phosphate permease GlpT is the only fosfomycin transporter in Pseudomonas aeruginosa. J. Bacteriol. 191:6968-6974.
14. de Cueto M, López L, Hernández JR, Morillo C, Pascual A. 2006. In vitro activity of fosfomycin against extended-spectrum-beta-lactamase- producing Escherichia coli and Klebsiella pneumoniae: Comparison of susceptibility testing procedures. Antimicrob. Agents Chemother. 50:368-370.
15. López-Cerero L, de Cueto M, Díaz-Guerrero MA, Pascual A, Morillo C. 2007. Evaluation of the Etest method for fosfomycin susceptibility of ESBLproducing Klebsiella pneumoniae. J. Antimicrob. Chemother. 59:810-812.